Literature DB >> 11803370

Recent insights into the mechanism of glucocorticosteroid-induced apoptosis.

C W Distelhorst1.   

Abstract

Glucocorticosteroid hormones induce apoptosis in lymphocytes. Therefore, glucocorticoids are commonly used as immunosuppressive and chemotherapeutic agents. This review examines many facets of the process by which glucocorticoids induce apoptosis. This process is divided into three stages, an initiation stage that involves glucocorticoid receptor-mediated gene regulation, a decision stage that involves the counterbalancing influence of prosurvival and proapoptotic factors, and the execution stage which involves caspase and endonuclease activation. Many aspects of glucocorticoid-induced apoptosis, such as mitochondrial dysfunction and caspase activation, are important steps in virtually all forms of apoptosis. But the process glucocorticoid-induced apoptosis differs from other forms of apoptosis in terms of initiation at the transcriptional level and involvement of the multicatalytic proteasome and calcium. Moreover, the abundant opportunity for crosstalk between the glucocorticoid receptor and other signaling pathways increases the complexity of glucocorticoid-induced apoptosis and its regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803370     DOI: 10.1038/sj.cdd.4400969

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  66 in total

1.  Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells.

Authors:  Margaret E Tome; Melba C Jaramillo; Margaret M Briehl
Journal:  Free Radic Biol Med       Date:  2011-09-10       Impact factor: 7.376

2.  Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε.

Authors:  Moammir H Aziz; Hong Shen; Carl G Maki
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

3.  BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo.

Authors:  Miriam Erlacher; Ewa M Michalak; Priscilla N Kelly; Verena Labi; Harald Niederegger; Leigh Coultas; Jerry M Adams; Andreas Strasser; Andreas Villunger
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

Review 4.  Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases.

Authors:  Madhu Ramaswamy; Min Deng; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

5.  Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents.

Authors:  Zhi-Guo Liu; Li-Na Zhao; Ying-Wang Liu; Ting-Ting Li; Dai-Ming Fan; Jason J Chen
Journal:  J Mol Biol       Date:  2007-09-18       Impact factor: 5.469

6.  Apoptosis-inducing effect of recombinant Caspase-3 expressed by constructed eukaryotic vector on gastric cancer cell line SGC7901.

Authors:  Yuan-Gen Fu; Yao-Jun Qu; Kai-Chun Wu; Hui-Hong Zhai; Zhi-Guo Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells.

Authors:  Nagathihalli S Nagaraj; Nadarajah Vigneswaran; Wolfgang Zacharias
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-16       Impact factor: 4.553

8.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

9.  Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.

Authors:  Michael W Harr; Yiping Rong; Martin D Bootman; H Llewelyn Roderick; Clark W Distelhorst
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

10.  Mitochondria are the primary source of the H(2)O(2) signal for glucocorticoid-induced apoptosis of lymphoma cells.

Authors:  Margaret E Tome; Kristy Lee; Melba C Jaramillo; Margaret M Briehl
Journal:  Exp Ther Med       Date:  2012-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.